Philipp Sander,
Scripps Research Institute | # of Grants: 1 |
Grants
Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 |
Cancer | Dissertation Awards |
Publications
Research Portfolio |
Funding Opportunities |
Scripps Research Institute | # of Grants: 1 |
Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 |
Cancer | Dissertation Awards |